Detalhe da pesquisa
1.
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.
Blood
; 140(22): 2348-2357, 2022 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-35921541
2.
Determinants of frontline tyrosine kinase inhibitor choice for patients with chronic-phase chronic myeloid leukemia: A study from the Registro Italiano LMC and Campus CML.
Cancer
; 129(17): 2637-2644, 2023 09 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37354090
3.
COVID-19 infection in chronic myeloid leukaemia after one year of the pandemic in Italy. A Campus CML report.
Br J Haematol
; 196(3): 559-565, 2022 02.
Artigo
Inglês
| MEDLINE | ID: mdl-34636033
4.
Prospective assessment of NGS-detectable mutations in CML patients with nonoptimal response: the NEXT-in-CML study.
Blood
; 135(8): 534-541, 2020 02 20.
Artigo
Inglês
| MEDLINE | ID: mdl-31877211
5.
The Italian Multicentric Randomized OPTkIMA Trial on Fixed vs Progressive Intermittent TKI Therapy in CML Elderly Patients: 3-Years of Molecular Response and Quality of Life Monitoring After Completing the Treatment Plan.
Clin Lymphoma Myeloma Leuk
; 24(5): 323-331, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38369436
6.
Bendamustine in chronic lymphocytic leukemia: outcome according to different clinical and biological prognostic factors in the everyday clinical practice.
Am J Hematol
; 88(11): 955-60, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23861234
7.
Molecular response and quality of life in chronic myeloid leukemia patients treated with intermittent TKIs: First interim analysis of OPTkIMA study.
Cancer Med
; 10(5): 1726-1737, 2021 03.
Artigo
Inglês
| MEDLINE | ID: mdl-33594821
8.
Managing chronic myeloid leukemia for treatment-free remission: a proposal from the GIMEMA CML WP.
Blood Adv
; 3(24): 4280-4290, 2019 12 23.
Artigo
Inglês
| MEDLINE | ID: mdl-31869412
9.
Excellent outcomes of 2G-TKI therapy after imatinib failure in chronic phase CML patients.
Oncotarget
; 9(18): 14219-14227, 2018 Mar 06.
Artigo
Inglês
| MEDLINE | ID: mdl-29581839
10.
Burkitt lymphoma in adolescents and young adults: management challenges.
Adolesc Health Med Ther
; 8: 11-29, 2017.
Artigo
Inglês
| MEDLINE | ID: mdl-28096698
11.
Minimal Residual Disease Assessment and Risk-based Therapy in Acute Lymphoblastic Leukemia.
Clin Lymphoma Myeloma Leuk
; 17S: S2-S9, 2017 07.
Artigo
Inglês
| MEDLINE | ID: mdl-28760298
12.
Corrigendum to "Venetoclax in combination with hypomethylating agents in previously untreated patients with acute myeloid leukemia ineligible for intensive treatment: a real-life multicenter experience" [Leukemia Res. 114 (March 2022) 106803].
Leuk Res
; 115: 106811, 2022 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-35219543
13.
The predictive value of positron emission tomography scanning performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease.
Haematologica
; 91(4): 475-81, 2006 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-16585014
14.
Modern immunotherapy of adult B-lineage acute lymphoblastic leukemia with monoclonal antibodies and chimeric antigen receptor modified T cells.
Mediterr J Hematol Infect Dis
; 7(1): e2015001, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-25574360
15.
Clinical Characteristics and Outcome of West Nile Virus Infection in Patients with Lymphoid Neoplasms: An Italian Multicentre Study.
Hemasphere
; 4(3): e395, 2020 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32647801
16.
Role of blood cells dynamism on hemostatic complications in low-risk patients with essential thrombocythemia.
Intern Emerg Med
; 10(4): 451-60, 2015 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-25585678
17.
Current and future management of Ph/BCR-ABL positive ALL.
Expert Rev Anticancer Ther
; 14(6): 723-40, 2014 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-24611626
18.
EUTOS score predicts long-term outcome but not optimal response to imatinib in patients with chronic myeloid leukaemia.
Leuk Res
; 37(11): 1457-60, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23993428
19.
Positron emission tomography in the staging of patients with Hodgkin's lymphoma. A prospective multicentric study by the Intergruppo Italiano Linfomi.
Ann Hematol
; 86(12): 897-903, 2007 Dec.
Artigo
Inglês
| MEDLINE | ID: mdl-17701410